Anonymous ID: b33009 Feb. 12, 2023, 9:20 a.m. No.18332474   ๐Ÿ—„๏ธ.is ๐Ÿ”—kun

>>18332333

>>18332198

LRD

JAN 9, 2024

Launch Readiness Date (LRD) - The Final Commit-to-Launch Poll is conducted approximately five minutes before launch to confirm readiness to launch. A "Go" statement is required from all parties polled to enter into terminal count. Mandatory launch constraints cannot be waived after the start of terminal launch countdown.

https://pace.oceansciences.org/timeline.htm

Anonymous ID: b33009 Feb. 12, 2023, 9:32 a.m. No.18332553   ๐Ÿ—„๏ธ.is ๐Ÿ”—kun   >>2579

>>18332520

Antiparasitic and Antifungal Medications for Targeting Cancer Cells Literature Review and Case Studies

https://pubmed.ncbi.nlm.nih.gov/31202208/

 

https://pubmed.ncbi.nlm.nih.gov/?term=Antiparasitic+cancer&ac=yes&format=summary&sort=relevance&sort_order=desc&size=10

 

https://pubmed.ncbi.nlm.nih.gov/?term=Antifungal+cancer&ac=yes&format=summary&sort=relevance&sort_order=desc&size=10

Anonymous ID: b33009 Feb. 12, 2023, 9:53 a.m. No.18332713   ๐Ÿ—„๏ธ.is ๐Ÿ”—kun   >>2743

>>18332682

Pfizer chief Albert Bourla wins US$1M Genesis Prize

Jan. 19, 2022 2:04 a.m. EST

 

Share

facebooktwitterreddit More share options

JERUSALEM - Albert Bourla, chairman and chief executive of global pharmaceutical giant Pfizer Inc., was awarded on Wednesday the prestigious Genesis Prize for his efforts in leading the development of a COVID-19 vaccine.

 

https://www.ctvnews.ca/business/pfizer-chief-albert-bourla-wins-us-1m-genesis-prize-1.5745660

 

2022 Pulitzer Prizes

JOURNALISM

https://www.pulitzer.org/prize-winners-by-year

 

prizes

get yer prizes